Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedicalMix
Sant Cugat del Vallès, Barcelona, Spain
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
MedicalMix's spin-off, Retinset, has successfully completed a Phase 1 clinical trial for its lead program BSL01, a first-in-class eye drop formulation for the treatment of early-stage Diabetic Retinopathy. The parent company MedicalMix operates as a major commercial provider of ophthalmic surgical products and diagnostic equipment in Spain and Portugal.
- Therapeutic areas
- Ophthalmology
- Modalities
- Medical DeviceSmall moleculeEye dropIntraocular LensRegenerative medicine
- Industry
- Biotech
02
Partnerships
PhysIOLQuantel MedicalCanon Medical Eye CareLeicaBTI Biotechnology InstituteOptikonKatenaSurgiCube
Beyond the preview
Go deeper on MedicalMix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MedicalMix.